Gum arabic shows early promise for weight and blood sugar

Gum arabic, a fibre from the Acacia senegal tree, has attracted interest as a low-cost supplement for metabolic health. Individual trials have pointed in promising directions for weight, BMI, fasting blood glucose and HbA1c, but the results have been inconsistent from one study to the next, and no one had pooled them to establish an overall effect. This review set out to do exactly that, comparing oral gum arabic against placebo across glycaemic, lipid and cardiometabolic outcomes in adults, including healthy people and those with type 2 diabetes or metabolic syndrome.

The authors systematically searched PubMed, Cochrane Central and Scopus for randomised controlled trials comparing any dose of oral gum arabic with placebo or standardised treatment. Six trials totalling 476 participants met the inclusion criteria. The outcomes assessed were BMI, weight, fasting blood glucose, HbA1c and lipid measures. Results were pooled with a random-effects model, with statistical checks on how much the studies disagreed with one another.

Gum arabic produced a significant reduction in BMI of 0.38 on average and in weight of 1.00, with the trials agreeing closely on both outcomes. Fasting blood glucose also fell significantly, by 29.76 on average, but here the studies disagreed sharply, which makes that figure far less dependable. A sub-analysis splitting healthy from non-healthy participants found the weight reduction held in the healthy group, at 0.99 on average. The authors themselves flag the limited number of trials and short follow-up periods as reasons for caution.

This is the first quantitative pooling of the gum arabic trials, so it moves the question on from scattered, contradictory individual studies to a single overall estimate. The weight and BMI findings are the most solid part of the picture, because the trials agreed; the glucose finding is the shakiest, because they did not. What it cannot yet tell us is whether the effects persist beyond short trial periods, what dose works best, or how gum arabic compares with better-studied fibres. More and longer trials would be needed before it earns a firm place in metabolic health.

The honest reading is that gum arabic shows a real but small signal on weight and BMI, and a much less certain one on blood sugar. A weight change of around 1.00 over a short trial is modest, not transformative. If you follow supplement research, this is one to watch rather than one to bank on: six trials and 476 people is a thin foundation, and the authors say as much. Nothing here speaks to long-term effects, because the follow-up periods were short.